SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-25 |
| Reported value | $118,022,825 |
| Positions | 259 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| GILEAD SCIENCES INC | GILD | COM | $2,580,621 | 20,426 |
| VERTEX PHARMACEUTICALS INC | VRTX | COM | $2,484,643 | 5,002 |
| INVITATION HOMES INC | INVH | COM | $2,205,330 | 73,000 |
| ASTRAZENECA PLC | AZN | ORD | $2,160,530 | 11,394 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $1,711,283 | 48,355 |
| ARGENX SE | ARGX | SPONSORED ADR | $1,675,553 | 1,806 |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $1,639,340 | 9,727 |
| INCYTE CORP | INCY | COM | $1,638,165 | 14,451 |
| AXSOME THERAPEUTICS INC. | AXSM | COM | $1,598,593 | 6,531 |
| APOGEE THERAPEUTICS INC | APGE | COM | $1,530,775 | 11,533 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.